NFlection Therapeutics
PrivateLast Round
Debt
Jul 20, 2023
Total Funding Raised
$44M
Company Overview
NFlection Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Debt round in July 2023.
NFlection Therapeutics is a biopharmaceutical company focused on the discovery and development of targeted topical therapies for rare dermatological disorders driven by aberrant RAS pathway activation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NFlection Therapeutics Comparables
Compare NFlection Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DermBiont | 83% | |
| Healx | 77% | |
| Nobelpharma Co., Ltd. | 77% |
For institutional investors. Book with your work email.
NFlection Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 20, 2023 | ||||
| Series B | Jun 21, 2022 | ||||
| Series A | Jun 9, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NFlection Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series A |
| venBio | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 60% MoM.
- Jun 21, 2022
$20M round led by Children's Tumor Foundation.
For institutional investors. Book with your work email.
NFlection Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NFlection Therapeutics's valuation, stock price, and market status.
Is NFlection Therapeutics a public or private company?
NFlection Therapeutics is a private company.
What is the current stock price of NFlection Therapeutics?
NFlection Therapeutics is a private company, so its shares have no public market price. Caplight tracks NFlection Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NFlection Therapeutics worth (valuation)?
Valuation information for NFlection Therapeutics is not publicly available.
Can I buy NFlection Therapeutics stock?
NFlection Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NFlection Therapeutics's last funding round?
NFlection Therapeutics's most recent funding round was Debt on July 20, 2023.
Who are the main investors in NFlection Therapeutics?
Key investors in NFlection Therapeutics include F-Prime Capital, venBio.
Will NFlection Therapeutics IPO soon?
No public IPO plans have been announced for NFlection Therapeutics.
How can I track NFlection Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NFlection Therapeutics's shares on secondary markets.